Antibe Therapeutics Inc(Pre-Merger) ATBPF

Healthcare

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.

GREY:ATBPF - Post by User

Antibe Therapeutics Inc(Pre-Merger) > Hiring Stern

<< Previous

Bullboard Posts

Next >>

Comment by themagicboxon Aug 19, 2020 10:20am

212 Views

Post# 31427890

RE:RE:RE:RE:RE:RE:RE:RE:Hiring Stern

Here is someone who doesnt know how to compare things.

And that fact that you call the phase 2 data a "fiasco" and concluding stern's (yet to be) marketing campaign for ATE, to already be hinted at in the chicago press demonstrates: poor crtitical analysis, mind reading, unqualified certainty, and you havent done your due diligience.

You sound just like that other dip "lookingforclues(less)". Same song, different handle. Except you dont have the same hardon for MUGs.

Blazesb wrote: Who do you trust on Covid 19: Donald Trump or Dr. Anthony Fauci?

Who do you trust on Antibe phase 2 data: Dan Legault or Dr. Wallace?

Stern gave a hint to the answer with Dr. Wallace's editorial in the Chicago press. It'll be interesting to watch them pursue this line. Burnish Dr. Wallace and eventually address the phase 2 data fiasco.

That's the only path forward for Antibe.